Pharma Two B to Present Additional Positive Results from
Results showed P2B001, a once-daily fixed-dose combination of low dose pramipexole and low dose rasagiline, showed comparable efficacy to marketed...
Source: globenewswire.com
Stay updated with breaking news from Dan Teleman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results showed P2B001, a once-daily fixed-dose combination of low dose pramipexole and low dose rasagiline, showed comparable efficacy to marketed...